386 related articles for article (PubMed ID: 14982607)
21. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions.
Shu J; Sun G; Liu H; Liu J
Acta Oncol; 2007; 46(7):1004-11. PubMed ID: 17917830
[TBL] [Abstract][Full Text] [Related]
23. [Vascular endothelial growth factor in benign and malignant pleural effusions].
Kaya A; Poyraz B; Celik G; Ciledag A; Gulbay BE; Savas H; Savas I
Arch Bronconeumol; 2005 Jul; 41(7):376-9. PubMed ID: 16029730
[TBL] [Abstract][Full Text] [Related]
24. VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes.
Hooper CE; Elvers KT; Welsh GI; Millar AB; Maskell NA
Lung Cancer; 2012 Aug; 77(2):443-9. PubMed ID: 22487430
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
[TBL] [Abstract][Full Text] [Related]
26. Role of VEGF-stromal cell-derived factor-1alpha/CXCL12 axis in pleural effusion of lung cancer.
Economidou F; Antoniou KM; Soufla G; Lasithiotaki I; Karagiannis K; Lymbouridou R; Proklou A; Spandidos DA; Siafakas NM
J Recept Signal Transduct Res; 2010 Jun; 30(3):154-60. PubMed ID: 20196627
[TBL] [Abstract][Full Text] [Related]
27. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
[TBL] [Abstract][Full Text] [Related]
28. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
Elsammak M MY; Morsi TS; Khamis HI; Ragab MS; Zaki MA; Abdel-Hadi M; Hassan HA
Ann Clin Biochem; 2007 May; 44(Pt 3):264-72. PubMed ID: 17456294
[TBL] [Abstract][Full Text] [Related]
29. [Serum tumor necrosis factor alpha (TNF-alpha) concentration correlates with soluble adhesion molecules and vascular endothelial growth factor (VEGF) in rheumatoid arthritis].
Klimiuk PA; Sierakowski S; Fiedorczyk M; Chwiećko J
Przegl Lek; 2004; 61(2):86-9. PubMed ID: 15230147
[TBL] [Abstract][Full Text] [Related]
30. Elevated soluble CD26 levels in patients with tuberculous pleurisy.
Oshikawa K; Sugiyama Y
Int J Tuberc Lung Dis; 2001 Sep; 5(9):868-72. PubMed ID: 11573900
[TBL] [Abstract][Full Text] [Related]
31. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.
Lin FC; Chen YC; Chen FJ; Chang SC
Clin Immunol; 2005 Aug; 116(2):166-73. PubMed ID: 15897010
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
Momi H; Matsuyama W; Inoue K; Kawabata M; Arimura K; Fukunaga H; Osame M
Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
[TBL] [Abstract][Full Text] [Related]
33. Angiopoietin-2 levels are elevated in exudative pleural effusions.
Kalomenidis I; Kollintza A; Sigala I; Papapetropoulos A; Papiris S; Light RW; Roussos C
Chest; 2006 May; 129(5):1259-66. PubMed ID: 16685017
[TBL] [Abstract][Full Text] [Related]
34. Differentiating tuberculous from malignant pleural effusions: a scoring model.
Porcel JM; Vives M
Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
[TBL] [Abstract][Full Text] [Related]
35. The comparison of pleural fluid TNF-α levels in tuberculous and nontuberculous pleural effusion.
Damayanti N; Yudhawati R
Indian J Tuberc; 2020 Jan; 67(1):98-104. PubMed ID: 32192626
[TBL] [Abstract][Full Text] [Related]
36. Preliminary investigation of the clinical value of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in pericardial fluid in diagnosing malignant and tuberculous pericardial effusion.
Liu J; Zeng Y; Ma W; Chen S; Zheng Y; Ye S; Lan L; Weig HJ; Liu Q
Cardiology; 2010; 116(1):37-41. PubMed ID: 20424452
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-derived chemokine in malignant and tuberculous pleural effusions.
Okamoto M; Imaizumi K; Hasegawa Y; Hashimoto N; Sumida A; Shibazaki M; Takagi K; Shimokata K; Kawabe T
Respirology; 2007 Jul; 12(4):581-4. PubMed ID: 17587426
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters.
Bayram N; Karakan Y; Uyar M; Ozyurt B; Filiz A
Niger J Clin Pract; 2018 Jan; 21(1):59-62. PubMed ID: 29411725
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of soluble interleukin 2 receptor in differentiating tuberculous and carcinomatous pleural effusions.
Chang SC; Hsu YT; Chen YC; Lin CY
Arch Intern Med; 1994 May; 154(10):1097-101. PubMed ID: 8185423
[TBL] [Abstract][Full Text] [Related]
40. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
